Hodgkin & Non-Hodgkin Lymphoma

If you have been diagnosed with lymphoma, your team of Roswell Park specialists will evaluate all the options and work together to create a comprehensive treatment plan tailored to your specific disease. We bring together a whole team of medical professionals to assist you and your loved ones with a broad range of issues related to your diagnosis, treatment, and long-term health.

With approximately 500 inpatient admissions and 8,300 outpatient visits annually, Roswell Park’s Lymphoma Team has both the experience and expertise you need.

Roswell Park led the world’s first clinical research study that combined standard chemotherapy with rituximab (Rituxan®) to treat lymphoma. Today, the addition of rituximab to chemotherapy is the worldwide standard-of-care treatment for most B-cell lymphomas.

Our physicians are among the experts who set the National Comprehensive Cancer Network (NCCN) Guidelines, developed on the basis of scientific data, that annually recommend the best ways of preventing, detecting and treating specific types of lymphoma.

According to the 2014 Center for International Blood and Marrow Transplant Research report, Roswell Park achieved higher than expected one-year survival ratings for allogeneic blood and marrow transplants. The BlueCross BlueShield Association has named Roswell Park a Blue Distinction Center for Transplants® — one of only 83 in the nation to earn that title for BMT.